Industry
The partnership program aims to develop next-generation probiotics and therapeutics to modulate the gut microbiota to target areas like anxiety, depression and mental well-being.
It's the second agreement between Boehringer Ingelheim and BiomX focused on IBD. The first one in 2020.
Locus is developing a new class of precision engineered bacteriophage treatments for a diverse set of bacterial diseases.
New publication reveals how a keystone strain exerts potential to impact a spectrum of health outcomes through immune and metabolic regulation.
Industry
Sponsored by
SynBalance® ProBeautyShield has been selected as the ingredient of the year in beauty from within category.
The collaboration with ADM a premier global human and animal nutrition company will combine cutting-edge technologies to the pipeline of microbiome-focused innovation from Gnubiotics.
The solutions will aim to improve the diagnosis of diseases thanks to a more detailed analysis of the intestinal, oral, ocular, cancer or pulmonary microbiomes.
Patrice Cani (Université catholique de Louvain) discusses the future of Akkermansia municiphila.
George Paraskevakos (International Probiotics Association) discusses the challenges on microbiome space.
MaaT Pharma has established a comprehensive approach to restoring the patient-microbiome symbiosis in oncology.
